Clinical characteristics and 1-year outcome of hyponatremic patients hospitalized for heart failure

Polskie Archiwum Medycyny Wewnetrznej

Volumn 125, Issue 3, 2015, Pages 120-131

  Kapłon Cieślicka, Agnieszka ^a   Ozierański, Krzysztof ^a   Balsam, Paweł ^a   Tymińska, Agata ^a   Peller, Michał ^a   Galas, Michalina ^a   Wyzgał, Marcin ^a   Marchel, Michał ^a   Drozdz, Jarosław ^b   Opolski, Grzegorz ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Heart failure; Hospitalization; Hyponatremia; Prognosis; Sodium

Indexed keywords

CREATININE; HEMOGLOBIN;

ACUTE HEART FAILURE; ADULT; AGED; ARTICLE; BLOOD PRESSURE; BODY MASS; CAUSE OF DEATH; FEMALE; HEART FAILURE; HEMOGLOBIN DETERMINATION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; HYPONATREMIA; MAJOR CLINICAL STUDY; MALE; NEW YORK HEART ASSOCIATION CLASS; COMPLICATION; DISEASE COURSE; FOLLOW UP; MIDDLE AGED; MORTALITY; POLAND; PROGNOSIS; STATISTICS AND NUMERICAL DATA;

ADULT; CAUSE OF DEATH; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HOSPITALIZATION; HUMANS; HYPONATREMIA; MALE; MIDDLE AGED; POLAND; PROGNOSIS;

EID: 84928997678     PISSN: 00323772     EISSN: 18979483     Source Type: Journal    
DOI: 10.20452/pamw.2701     Document Type: Article

References (41)

1. Goldsmith SR. Hyponatremia and outcomes in patients with heart failure. Heart. 2012; 98: 1761-1762.
2. Hamaguchi S, Kinugawa S, Tsuchihashi-Makaya M, et al. Hyponatremia is an independent predictor of adverse clinical outcomes in hospitalized patients due to worsening heart failure. J Cardiol. 2014; 63: 182-188.
3. Ng TM, Cao DX, Patel KA, et al. Association of hyponatremia to diuretic response and incidence of increased serum creatinine levels in hospitalized patients with acute decompensated heart failure. Cardiology. 2014; 128: 333-342.
4. Sato N, Gheorghiade M, Kajimoto K, et al. Hyponatremia and in-hospital mortality in patients admitted for heart failure (from the ATTEND registry). Am J Cardiol. 2013; 111: 1019-1025.
5. Arévalo Lorido JC, Carretero Gómez J, Formiga F, et al; RICA Investigators. Hyponatremia as predictor of worse outcome in real world patients admitted with acute heart failure. Cardiol J. 2013; 20: 506-512.
6. Bettari L, Fiuzat M, Shaw LK, et al. Hyponatremia and long-term outcomes in chronic heart failure - an observational study from the Duke Databank for Cardiovascular Diseases. J Card Fail. 2012; 18: 74-81.
7. Spinar J, Parenica J, Vitovec J, et al. Baseline characteristics and hospital mortality in the Acute Heart Failure Database (AHEAD) Main registry. Crit Care. 2011; 15: R291.
8. Choi DJ, Han S, Jeon ES, et al. Characteristics, outcomes and predictors of long-term mortality for patients hospitalized for acute heart failure: a report from the korean heart failure registry. Korean Circ J. 2011; 41: 363-371.
9. Mohammed AA, van Kimmenade RR, Richards M, et al. Hyponatremia, natriuretic peptides, and outcomes in acutely decompensated heart failure: results from the International Collaborative of NT-proBNP Study. Circ Heart Fail. 2010; 3: 354-361.
10. Gheorghiade M, Abraham WT, Albert NM, et al. Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry. Eur Heart J. 2007; 28: 980-988.
11. Gheorghiade M, Rossi JS, Cotts W, et al. Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial. Arch Intern Med. 2007; 167: 1998-2005.
12. Levy WC, Mozaffarian D, Linker DT, et al. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation. 2006; 113: 1424-1433.
13. Klein L, O'Connor CM, Leimberger JD, et al. Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study. Circulation. 2005; 111: 2454-2460.
14. Lee DS, Austin PC, Rouleau JL, et al. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA. 2003; 290: 2581-2587.
15. Marcinkiewicz M, Ponikwicka K, Szpakowicz A, et al. Cardiogenic pulmonary oedema: alarmingly poor long term prognosis. Analysis of risk factors. Kardiol Pol. 2013; 71: 712-720.
16. Maggioni AP, Dahlström U, Filippatos G, et al. EURObservational Research Programme: the Heart Failure Pilot Survey (ESC-HF Pilot). Eur J Heart Fail. 2010; 12: 1076-1084.
17. Maggioni AP, Dahlström U, Filippatos G, et al. EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot). Eur J Heart Fail. 2013; 15: 808-817.
18. Kapłon-Cieślicka A, Balsam P, Ozierański K, et al. Resting heart rate at hospital admission and its relation to hospital outcome in patients with heart failure. Cardiol J. 2014; 21: 425-433.
19. O'Connor CM, Abraham WT, Albert NM, et al. Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). Am Heart J. 2008; 156: 662-673.
20. Balling L, Schou M, Videbæk L, et al Danish Heart Failure Clinics Network. Prevalence and prognostic significance of hyponatraemia in outpatients with chronic heart failure. Eur J Heart Fail. 2011; 13: 968-973.
21. Bavishi C, Ather S, Bambhroliya A, et al. Prognostic significance of hyponatremia among ambulatory patients with heart failure and preserved and reduced ejection fractions. Am J Cardiol. 2014; 113: 1834-1838.
22. Fonarow GC, Heywood JT, Heidenreich PA, et al. Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2007; 153: 1021-1028.
23. Nakamura T, Funayama H, Yoshimura A, et al. Possible vascular role of increased plasma arginine vasopressin in congestive heart failure. Int J Cardiol. 2006; 106: 191-195.
24. Blanchard A, Steichen O, De Mota N, et al. An abnormal apelin/vasopressin balance may contribute to water retention in patients with the syndrome of inappropriate antidiuretic hormone (SIADH) and heart failure. J Clin Endocrinol Metab. 2013; 98: 2084-2089.
25. Rosner MH, Ronco C. Hyponatremia in heart failure: the role of arginine vasopressin and its antagonism. Congest Heart Fail. 2010; 16: S7-S14.
26. LeJemtel TH, Serrano C. Vasopressin dysregulation: hyponatremia, fluid retention and congestive heart failure. Int J Cardiol. 2007; 120: 1-9.
27. Imamura T, Kinugawa K, Hatano M, et al. Low Cardiac Output Stimulates Vasopressin Release in Patients With Stage D Heart Failure. Circ J. 2014; 78: 2259-2267.
28. Porcel A, Díaz F, Rendón P, et al. Dilutional hyponatremia in patients with cirrhosis and ascites. Arch Intern Med. 2002; 162: 323-328.
29. Izzedine H, Fardet L, Launay-Vacher V, et al. Angiotensin-converting enzyme inhibitor-induced syndrome of inappropriate secretion of antidiuretic hormone: case report and review of the literature. Clin Pharmacol Ther. 2002; 71: 503-507.
30. Zaki SA, Bhongade S, Shanbag P. Enalapril induced severe hyponatremia and altered sensorium in a child. Indian J Pharmacol. 2011; 43: 605-606.
31. Rusinaru D, Buiciuc O, Leborgne L, et al. Relation of serum sodium level to long-term outcome after a first hospitalization for heart failure with preserved ejection fraction. Am J Cardiol. 2009; 103: 405-410.
32. Qamar S, Hassan W, Sra J, et al. Hyponatremia Associated with Flecainide: Case Series. Circulation. 2012; 126: A14890.
33. Singla S, Strobel AL, Deshmukh AJ, et al. Amiodarone-related hyponatremia: rare but potentially lethal. Am J Ther. 2013; 20: 564-565.
34. Pham L, Shaer AJ, Marnejon T. Hyponatremia - a rare but serious complication of amiodarone: a case report and review of the literature. Case Rep Nephrol Urol. 2013; 3: 46-50.
35. Vazquez R, Bayes-Genis A, Cygankiewicz I, et al. The MUSIC Risk score: a simple method for predicting mortality in ambulatory patients with chronic heart failure. Eur Heart J. 2009; 30: 1088-1096.
36. Rusinaru D, Tribouilloy C, Berry C, et al. Relationship of serum sodium concentration to mortality in a wide spectrum of heart failure patients with preserved and with reduced ejection fraction: an individual patient data meta-analysis: Meta-Analysis Global Group in Chronic heart failure (MAGGIC). Eur J Heart Fail. 2012; 14: 1139-1146.
37. Madan VD, Novak E, Rich MW. Impact of change in serum sodium concentration on mortality in patients hospitalized with heart failure and hyponatremia. Circ Heart Fail. 2011; 4: 637-643.
38. Konstam MA, Gheorghiade M, Burnett JC Jr, et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA. 2007; 297: 1319-1331.
39. Lanfear DE, Sabbah HN, Goldsmith SR, et al. Association of arginine vasopressin levels with outcomes and the effect of V2 blockade in patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial. Circ Heart Fail. 2013; 6: 47-52.
40. Hauptman PJ, Burnett J, Gheorghiade M, et al Everest Investigators. Clinical course of patients with hyponatremia and decompensated systolic heart failure and the effect of vasopressin receptor antagonism with tolvaptan. J Card Fail. 2013; 19: 390-397.
41. Rywik TM, Koziarek J, Piotrowski W, et al. Trends in heart failure mortality in Poland between 1980 and 2010. Pol Arch Med Wewn. 2013; 123: 664-671.